Search PDMR transactions

Notifier
Name of person with notification obligation
Mathias Svahn
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Mathias Svahn
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
NextCell Pharma AB
Issuer´s LEI code
549300PBFGB5JYKXGA45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subscription right/Unit right NextCell TR SE0015243407 Acquisition 500,000 Quantity 0.0135 SEK 05/06/2024 NASDAQ STOCKHOLM AB
Subscription right/Unit right NextCell TR SE0015243407 Disposal 500,000 Quantity 0.018 SEK 05/06/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
NextCell TR SE0015243407 Acquisition 05/06/2024 NASDAQ STOCKHOLM AB 500,000 (Quantity) 0.0135 SEK
NextCell TR SE0015243407 Disposal 05/06/2024 NASDAQ STOCKHOLM AB 500,000 (Quantity) 0.018 SEK
<< Back